Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

VMY-2-109 treatment leads to reduction in nicotine self-administration in vivo

Nov. 27, 2013

SUVN-A60203 and its effects on alcohol consumption

Nov. 21, 2013

BARDA exercises option for continued development of AverTox against nerve agents

Nov. 18, 2013

Otsuka and Lundbeck partner for nalmefene in Japan

Nov. 5, 2013

AEOL-10150 improves survival in mice exposed to lethal radiation

Oct. 31, 2013

FDA accepts filing for Bunavail NDA

Oct. 10, 2013

FDA grants Titan Pharmaceuticals meeting regarding Probuphine NDA

Sep. 30, 2013

BARDA exercises additional funding to develop Aeolus's drug for acute radiation syndrome

Sep. 20, 2013

FDA grants orphan drug designation to Soligenix's SGX-94

Sep. 18, 2013

NIH to fund UCLA alcoholism study of MediciNova's MN-166

Aug. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...